Shared by
beno
Fundamentals
N/a
Catalysts / News / Painting the picture
-Corona virus sympathy
-Health officials say virus vaccine development has 'no glitches'
-Feb 11 2020: $500m IPO @ $19 per share
-mRNA-1273 coronavirus vaccine sent for testing
-March 16 2020: First human trial of COVID-19 vaccine
-April 15 2020: PT increase to 41, Making new ATH's
-April 16 2020: Wins $483 Million US Government Award To Develop Coronavirus Vaccine
Technical Analysis
-Intraday pattern: Fade
-Levels: 47, 48.3, 49.5 - 49.6, 50.50
Original Plan / Strategy
First test short of 49.5 by 49.6 level with VWAP and half dollar confluence
Review
Level and confluence was good, got to appropriate size, covered first two lots too close to each other, last lot was a good cover, pullback form level didn't go as far as anticipated, it ended up consolidating at this level for 20 more minutes before continuing its move down.
Execution detail:
| Date/time | Symbol | Side | Price | Position |
|---|---|---|---|---|
| 2020-04-23 11:53:50 | MRNA | sell | $49.560 | short |
| 2020-04-23 11:54:13 | MRNA | sell | $49.530 | short |
| 2020-04-23 11:55:51 | MRNA | sell | $49.560 | short |
| 2020-04-23 11:56:47 | MRNA | buy | $49.450 | short |
| 2020-04-23 11:56:56 | MRNA | buy | $49.420 | short |
| 2020-04-23 11:56:56 | MRNA | buy | $49.430 | short |
| 2020-04-23 12:00:03 | MRNA | buy | $49.400 | 0 |
Leave a comment about this trade!
You need to log into your Tradervue account to leave a comment. If you don't have one,
it takes
just a few seconds to sign up, and it's free!